Celularity Share Price Today (NASDAQ: CELU)

Name: Celularity Share Price (NASDAQ: CELU) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Celularity share price is $1.79 & ₹154.06 as on 15 Jun 2025, 2.30 'hrs' IST

$1.79

▲

0.03

(1.7%)

Market is closed - opens 7 PM, 16 Jun 2025

View live Celularity share price in Dollar and Rupees. Guide to invest in Celularity stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Celularity, along with analyst recommendations, forecasts, and comprehensive financials.

Celularity share price movements

Today's Low: $1.72
Today's High: $1.80
$1.79
3.91%
Downside
Day's Volatility :4.44%
Upside
0.56%
52 Weeks Low: $1.00
52 Weeks High: $5.22
$1.79
44.09%
Downside
52 Weeks Volatility :80.83%
Upside
65.71%

Celularity (CELU) Returns

Period	Celularity Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	17.45%	-6.1%	0.0%
6 Months	-24.24%	-3.4%	0.0%
1 Year	-43.91%	-6.7%	0.0%
3 Years	-95.64%	11.8%	2.2%

Celularity (CELU) Key Statistics

in dollars & INR

Previous Close	$1.76
Open	$1.775
Today's High	$1.8
Today's Low	$1.72
Market Capitalization	$43.1M
Today's Volume	$18.7K
52 Week High	$5.22
52 Week Low	$1.0007
Revenue TTM	$54.2M
EBITDA	$-30.6M
Earnings Per Share (EPS)	$-2.36
Profit Margin	-106.77%
Quarterly Earnings Growth YOY	-0.61%
Return On Equity TTM	-232.51%

How to invest in Celularity Stock (CELU) from India?

It is very easy for Indian residents to invest directly in Celularity from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Celularity stock in both Indian Rupees (INR) and US Dollars (USD). Search for Celularity or CELU on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Celularity or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Celularity shares which would translate to 0.481 fractional shares of Celularity as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Celularity, in just a few clicks!

Returns in Celularity (CELU) for Indian investors in Rupees

The Celularity stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Celularity investment value today

Current value as on today

₹60,410

Returns

₹39,590

(-39.59%)

Returns from Celularity Stock

₹42,628 (-42.63%)

Dollar Returns*

₹3,039 (+3.04%)

Indian investors sentiment towards Celularity (CELU)

115%

Period: May 15, 2025 to Jun 14, 2025. Change in 30 Days versus previous period

Search interest for Celularity Stock from India on INDmoney has increased by 115% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Celularity

C V Starr & Co Inc
3.19%
Vanguard Group Inc
2.09%
Geode Capital Management, LLC
0.57%
BlackRock Inc
0.42%
State Street Corp
0.27%
Royal Bank of Canada
0.25%

Analyst Recommendation on Celularity

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Celularity(by analysts ranked 0 to 5 stars)

Analyst Forecast on Celularity Stock (CELU)

What analysts predicted

Upside of 39.66%

Target:

$2.50

Current:

$1.79

Insights on Celularity Stock (Ticker Symbol: CELU)

Price Movement
In the last 7 days, CELU stock has moved down by -15.9%
Increasing Revenue
Revenue is up for the last 3 quarters, 9.29M → 18.13M (in $), with an average increase of 24.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -13.29M → -26.78M (in $), with an average decrease of 101.5% per quarter
CELU vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 91.7% return, outperforming this stock by 137.1%
CELU vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 127.0% return, outperforming this stock by 222.8%
Price to Sales
ForCELU every $1 of sales, investors are willing to pay $0.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.8 for every $1 of sales.

Celularity Technicals Summary

Sell

Neutral

Buy

Celularity is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Celularity (CELU) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Celularity Inc	-14.22%	-24.24%	-43.91%	-95.64%	-82.74%
Regeneron Pharmaceuticals, Inc.	-11.02%	-27.05%	-49.42%	-5.02%	-10.81%
Beone Medicines Ltd	18.08%	52.93%	69.2%	101.57%	55.67%
Vertex Pharmaceuticals Incorporated	3.86%	-2.68%	-3.83%	81.53%	66.4%
Alnylam Pharmaceuticals, Inc.	7.76%	26.01%	95.45%	128.04%	132.45%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Celularity Inc	2.28	NA	NA	0.0	-2.33	-0.17	NA	0.39
Regeneron Pharmaceuticals, Inc.	13.31	13.31	1.07	35.45	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.39	-0.11	-0.03	NA	32.42
Vertex Pharmaceuticals Incorporated	32.84	NA	2.66	18.0	-0.06	0.12	NA	64.2
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.93	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Celularity Inc	Buy	$43.1M	-82.74%	2.28	-106.77%
Regeneron Pharmaceuticals, Inc.	Buy	$56.0B	-10.81%	13.31	31.94%
Beone Medicines Ltd	NA	$32.0B	55.67%	NA	-9.4%
Vertex Pharmaceuticals Incorporated	Buy	$116.2B	66.4%	32.84	-8.91%
Alnylam Pharmaceuticals, Inc.	Buy	$38.9B	132.45%	NA	-11.49%

About Celularity

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degenerative disease; and PDA-002 for treating facioscapulohumeral muscular dystrophy. The company is also developing pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. In addition, it produces, sells, and licenses products used in surgical and wound care markets, such as Biovance, Biovance 3L, Rebound, Interfyl, and Centaflex; and collects, processes, and stores umbilical cord and placental blood and tissue after full-term pregnancies under the LifebankUSA brand. Celularity Inc. has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products; and research collaboration services agreement with Regeneron Pharmaceuticals, Inc. to support the research of allogeneic cell therapy candidates. Celularity Inc. was founded in 1998 and is headquartered in Florham Park, New Jersey.

Organization	Celularity
Employees	123
CEO	Dr. Robert Joseph Hariri M.D., Ph.D.
Industry	Healthcare

Management People of Celularity

Name	Title
Dr. Robert Joseph Hariri M.D., Ph.D.	Founder, CEO & Chairman
Mr. Carlos Ramirez	SVP of Investor Relations
Dr. Stephen A. Brigido D.P.M.	President of Degenerative Diseases
Sharmila Koppisetti M.D.	Senior Vice President of Clinical Dev. Immunology & Drug Safety
Mr. Tim Wilk	Senior Vice President of Technical Operations
Mr. David Jakob Lemus CPA, M.S., MBA	Treasurer

Important FAQs about investing in CELU Stock from India :

Can Indians buy Celularity shares?

Yes, Indians can invest in the Celularity (CELU) from India.

With INDmoney, you can buy Celularity at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Celularity at zero transaction cost.

How can I buy Celularity shares from India?

It is very easy to buy Celularity from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Celularity (CELU) be purchased?

Yes, you can buy fractional shares of Celularity with INDmoney app.

What are the documents required to start investing in Celularity stocks?

To start investing in Celularity, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is Celularity share price today?

Celularity share price today stands at $1.79, Open: $1.78 ; Previous Close: $1.76 ; High: $1.80 ; Low: $1.72 ; 52 Week High: $5.22 ; 52 Week Low: $1.00.

The stock opens at $1.78, after a closing price of $1.76. The stock reached a daily high of $1.80 and a low of $1.72, with a 52-week high of $5.22 and a 52-week low of $1.00.